David Watkins
Medical Oncology · Midland, TXNPI 1770526642
Payments from drug & device makers
$511,825in general payments, 2019–2025
Across 351 payments — averaging $1458.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$217K
- E.r. Squibb & Sons, L.L.C.$116K
- Incyte Corporation$109K
- Janssen Research & Development, LLC$46K
- Eli Lilly$15K
- Pharmacyclics LLC, An Abbvie Company$7K
- plus $1K from 6 others
What the payments were for
- Food & beverage$15147%
- Education$17253%
General payments by program year
19
20
21
22
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 6 | $216,883 |
| E.r. Squibb & Sons, L.L.C. | 23 | $116,084 |
| Incyte Corporation | 166 | $109,474 |
| Janssen Research & Development, LLC | 123 | $46,082 |
| Eli Lilly | 3 | $14,879 |
| Pharmacyclics LLC, An Abbvie Company | 22 | $7,146 |
| Bristol Myers Squibb | 1 | $952 |
| Johnson & Johnson | 2 | $160 |
| AstraZeneca | 2 | $108 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Gilead | 1 | $12 |
How this compares
$511,825 in reported general payments places this provider in the 65th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Midland
- Hagop KantarjianHouston$100.5M
- Timothy YapHouston$56.7M
- Yasir ElaminHouston$41.3M
- David HongHouston$31.6M
- Guillermo Garcia-ManeroHouston$31.6M
- Jason WestinHouston$30.8M
- Sawsan RashdanDallas$29.9M
- Lucia MasarovaHouston$29.7M
- Jordi Rodon AhnertHouston$28.1M
- Sarina Piha PaulHouston$26M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.